These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9475712)

  • 1. Definition of adverse reactions in clinical trials of a behavioral intervention. NIMH Multisite HIV Prevention Trial.
    AIDS; 1997 Dec; 11 Suppl 2():S55-7. PubMed ID: 9475712
    [No Abstract]   [Full Text] [Related]  

  • 2. Conceptual basis and procedures for the intervention in a multisite HIV prevention trial. NIMH Multisite HIV Prevention Trial.
    AIDS; 1997 Dec; 11 Suppl 2():S29-35. PubMed ID: 9475709
    [No Abstract]   [Full Text] [Related]  

  • 3. Methodological overview of a multisite HIV prevention trial for populations at risk for HIV. NIMH Multisite HIV Prevention Trial.
    AIDS; 1997 Dec; 11 Suppl 2():S1-11. PubMed ID: 9475706
    [No Abstract]   [Full Text] [Related]  

  • 4. Endpoints and other measures in a multisite HIV prevention trial: rationale and psychometric properties. NIMH Multisite HIV Prevention Trial.
    AIDS; 1997 Dec; 11 Suppl 2():S37-47. PubMed ID: 9475710
    [No Abstract]   [Full Text] [Related]  

  • 5. Demographic and behavioral predictors of sexual risk in a multisite HIV prevention trial. NIMH Multisite HIV Prevention Trial.
    AIDS; 1997 Dec; 11 Suppl 2():S21-7. PubMed ID: 9475708
    [No Abstract]   [Full Text] [Related]  

  • 6. Quality control and quality assurance in HIV prevention research: model from a multisite HIV prevention trial. NIMH Multisite HIV Prevention Trial.
    AIDS; 1997 Dec; 11 Suppl 2():S49-53. PubMed ID: 9475711
    [No Abstract]   [Full Text] [Related]  

  • 7. Collecting sexually transmitted disease clinic chart data in multisite studies. NIMH Multisite HIV Prevention Trial.
    AIDS; 1997 Dec; 11 Suppl 2():S59-63. PubMed ID: 9475713
    [No Abstract]   [Full Text] [Related]  

  • 8. Screening, recruiting and predicting retention of participants in a multisite HIV prevention trial. NIMH Multisite HIV Prevention Trial.
    AIDS; 1997 Dec; 11 Suppl 2():S13-9. PubMed ID: 9475707
    [No Abstract]   [Full Text] [Related]  

  • 9. Ethical issues in the NIMH Collaborative HIV/STD Prevention Trial.
    NIMH Collaborative HIV/STD Prevention Trial Group
    AIDS; 2007 Apr; 21 Suppl 2():S69-80. PubMed ID: 17413266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sexually transmitted disease and HIV prevalence and risk factors in concentrated and generalized HIV epidemic settings.
    NIMH Collaborative HIV/STD Prevention Trial Group
    AIDS; 2007 Apr; 21 Suppl 2():S81-90. PubMed ID: 17413267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of populations represented in the NIMH Collaborative HIV/STD Prevention Trial.
    NIMH Collaborative HIV/STD Prevention Trial Group
    AIDS; 2007 Apr; 21 Suppl 2():S19-28. PubMed ID: 17413260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and concepts of the NIMH Collaborative HIV/STD Prevention Trial.
    van Griensven F; Kalichman SC
    AIDS; 2007 Apr; 21 Suppl 2():S1-2. PubMed ID: 17413257
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of the data safety and monitoring board in an international trial.
    NIMH Collaborative HIV/STD Prevention Trial
    AIDS; 2007 Apr; 21 Suppl 2():S99-102. PubMed ID: 17413269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The community popular opinion leader HIV prevention programme: conceptual basis and intervention procedures.
    NIMH Collaborative HIV/STD Prevention Trial Group
    AIDS; 2007 Apr; 21 Suppl 2():S59-68. PubMed ID: 17413265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formative study conducted in five countries to adapt the community popular opinion leader intervention.
    NIMH Collaborative HIV/STD Prevention Trial Group
    AIDS; 2007 Apr; 21 Suppl 2():S91-8. PubMed ID: 17413268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Informed consent: practices and views of investigators in a multinational clinical trial.
    Sabik L; Pace CA; Forster-Gertner HP; Wendler D; Bebchuk JD; Tavel JA; McNay LA; Killen J; Emanuel EJ; Grady C
    IRB; 2005; 27(5):13-8. PubMed ID: 16425476
    [No Abstract]   [Full Text] [Related]  

  • 17. Social-cognitive theory mediators of behavior change in the National Institute of Mental Health Multisite HIV Prevention Trial.
    Health Psychol; 2001 Sep; 20(5):369-76. PubMed ID: 11570651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some design issues in trials of microbicides for the prevention of HIV infection.
    Fleming TR; Richardson BA
    J Infect Dis; 2004 Aug; 190(4):666-74. PubMed ID: 15272392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The other side of the healthy relationships intervention: mental health outcomes and correlates of sexual risk behavior change.
    Kalichman SC
    AIDS Educ Prev; 2005 Feb; 17(1 Suppl A):66-75. PubMed ID: 15843118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral interventions--rationale, measurement, and effectiveness.
    Zenilman JM
    Infect Dis Clin North Am; 2005 Jun; 19(2):541-62. PubMed ID: 15963887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.